Infection & chemotherapy
-
Infection & chemotherapy · Jun 2021
Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients.
The antiviral agent favipiravir is an RNA-dependent RNA polymerase (RdRp) inhibitor. ⋯ We found that initiation of favipiravir within the first 72 h after the onset of disease symptoms reduced fatality in patients with COVID-19.